The Deductive Reasoning
Biotron discovered in 2003 that the E Protein of the RNA virus, SARS-CoV-1, enables ion transfer that is essential for viral replication.
Biotron developed a compound, BIT036, that inhibited the ion channeling of the E Protein, and therefore stopped viral replicationin vitro.
Biotron then focused on HIV (SARS1 was finished) with same ion channel inhibiting technology in HIV, and phase 2 results created a 'vaccine-like" effect for patients.
Biotron is now testing compounds on CoV-SARS-2.
The main difference between SARS 1, and SARS2, is in the S Protein and not the E Protein.
Therefore Biotron's compounds that worked on SARS1 will work on SARS2.
(There are some independent researchers in Saudi who also think so too.)
- Forums
- ASX - By Stock
- BIT
- BIT036- a likely candidate for curing COVID-19
BIT036- a likely candidate for curing COVID-19, page-23
-
-
- There are more pages in this discussion • 2,044 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.26M |
Open | High | Low | Value | Volume |
2.7¢ | 2.8¢ | 2.7¢ | $3.64K | 130.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 130927 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 55916 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 130927 | 0.027 |
7 | 539518 | 0.026 |
5 | 268646 | 0.025 |
2 | 249000 | 0.024 |
2 | 430000 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 55916 | 2 |
0.029 | 361626 | 2 |
0.030 | 60000 | 2 |
0.031 | 80000 | 3 |
0.032 | 500000 | 1 |
Last trade - 14.19pm 05/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |